Acer Therapeutics Inc
ACER
|
|
| |
|
| Trading Volume | 424,060 |
|
|
1.28 - 0.74 |
| Market Cap Full | $ 22M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | -69.8% | 21.7% |
| Q2 | - | - | 21.6% | -56.9% |
| Q3 | - | - | -10.5% | 10.3% |
| Q4 | - | - | 16.7% | 80.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| -7.6 | -12.5 | -62.6 | 15.7 | 1.4 | 3.7 | -5.7 | 47.1 | -35.5 | 1.7 | 7.1 | - |
| 2022 | |||||||||||
| -16.7 | 24 | 17.7 | -29.5 | 16 | -47.3 | 8.3 | 1.8 | 0.1 | -8.6 | - | 97.6 |
| 2021 | |||||||||||
| 38.3 | -13.7 | -1.3 | -4.5 | -1.4 | -2.4 | -10.5 | 2.7 | -2.4 | -8.5 | -12.8 | 17.1 |
| 2020 | |||||||||||
| 2.4 | -15.3 | -39.3 | 20.6 | 27.9 | 11.7 | 8.8 | -29 | 11.7 | -17.6 | 5.7 | 2.3 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.8 | 0 | -0.1 | -0.5 |
| Q2 | -0.3 | 0 | -0.2 | -0.6 |
| Q3 | -0.6 | 0 | 0 | -0.5 |
| Q4 | 0 | -0.5 | -1.1 | -0.5 |
| A | -1.7 | -1.7 | -1.1 | -2.1 |